Abbott Laboratories Net Income 2010-2025 | ABT

Abbott Laboratories annual/quarterly net income history and growth rate from 2010 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Abbott Laboratories net income for the quarter ending March 31, 2025 was $1.325B, a 8.16% increase year-over-year.
  • Abbott Laboratories net income for the twelve months ending March 31, 2025 was $13.502B, a 139.82% increase year-over-year.
  • Abbott Laboratories annual net income for 2024 was $13.402B, a 134.18% increase from 2023.
  • Abbott Laboratories annual net income for 2023 was $5.723B, a 17.45% decline from 2022.
  • Abbott Laboratories annual net income for 2022 was $6.933B, a 1.95% decline from 2021.
Abbott Laboratories Annual Net Income
(Millions of US $)
2024 $13,402
2023 $5,723
2022 $6,933
2021 $7,071
2020 $4,495
2019 $3,687
2018 $2,368
2017 $477
2016 $1,400
2015 $4,423
2014 $2,284
2013 $2,576
2012 $5,963
2011 $4,728
2010 $4,626
2009 $5,746
Abbott Laboratories Quarterly Net Income
(Millions of US $)
2025-03-31 $1,325
2024-12-31 $9,229
2024-09-30 $1,646
2024-06-30 $1,302
2024-03-31 $1,225
2023-12-31 $1,594
2023-09-30 $1,436
2023-06-30 $1,375
2023-03-31 $1,318
2022-12-31 $1,033
2022-09-30 $1,435
2022-06-30 $2,018
2022-03-31 $2,447
2021-12-31 $1,989
2021-09-30 $2,100
2021-06-30 $1,189
2021-03-31 $1,793
2020-12-31 $2,162
2020-09-30 $1,232
2020-06-30 $537
2020-03-31 $564
2019-12-31 $1,049
2019-09-30 $960
2019-06-30 $1,006
2019-03-31 $672
2018-12-31 $654
2018-09-30 $563
2018-06-30 $733
2018-03-31 $418
2017-12-31 $-828
2017-09-30 $603
2017-06-30 $283
2017-03-31 $419
2016-12-31 $798
2016-09-30 $-329
2016-06-30 $615
2016-03-31 $316
2015-12-31 $767
2015-09-30 $580
2015-06-30 $784
2015-03-31 $2,292
2014-12-31 $905
2014-09-30 $538
2014-06-30 $466
2014-03-31 $375
2013-12-31 $590
2013-09-30 $966
2013-06-30 $476
2013-03-31 $544
2012-12-31 $1,053
2012-09-30 $1,943
2012-06-30 $1,725
2012-03-31 $1,242
2011-12-31 $1,619
2011-09-30 $303
2011-06-30 $1,943
2011-03-31 $864
2010-12-31 $1,441
2010-09-30 $891
2010-06-30 $1,292
2010-03-31 $1,003
2009-12-31 $1,539
2009-09-30 $1,480
2009-06-30 $1,288
2009-03-31 $1,439
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $216.470B $41.950B
Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson.
Stock Name Country Market Cap PE Ratio
Boston Scientific (BSX) United States $153.537B 38.44
Stryker (SYK) United States $147.836B 30.91
EssilorLuxottica (ESLOY) France $131.607B 0.00
Medtronic (MDT) Ireland $115.044B 16.31
Lonza Group Ag (LZAGY) Switzerland $49.188B 0.00
Haleon (HLN) United Kingdom $42.812B 24.44
ResMed (RMD) United States $38.280B 28.75
GE HealthCare Technologies (GEHC) United States $33.957B 16.12
Agilent Technologies (A) United States $31.827B 20.75
Terumo (TRUMY) Japan $24.178B 31.40
Koninklijke Philips (PHG) Netherlands $23.630B 16.58
Insulet (PODD) United States $19.773B 77.61
Zimmer Biomet Holdings (ZBH) United States $18.319B 11.77
Baxter (BAX) United States $14.046B 10.49
Smith & Nephew SNATS (SNN) United Kingdom $13.262B 0.00
Sunny Optical Technology (SNPTF) China $10.417B 0.00
Demant (WILYY) Denmark $8.633B 0.00
Bio-Rad Laboratories (BIO) United States $6.647B 23.13
Lantheus Holdings (LNTH) United States $4.951B 12.49
Prestige Consumer Healthcare (PBH) United States $3.734B 16.68
Perrigo (PRGO) Ireland $3.704B 9.39
Haemonetics (HAE) United States $3.544B 16.14
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.300B 27.42
ICU Medical (ICUI) United States $2.994B 22.08
LeMaitre Vascular (LMAT) United States $1.803B 40.31
QuidelOrtho (QDEL) United States $1.711B 11.77
AtriCure (ATRC) United States $1.448B 0.00
Acuren (TIC) United States $1.408B 0.00
Green Thumb Industries (GTBIF) United States $1.251B 28.13
AdaptHealth (AHCO) United States $1.235B 12.53
Phibro Animal Health (PAHC) United States $1.181B 15.10
Neogen (NEOG) United States $1.037B 13.28
BioLife Solutions (BLFS) United States $0.993B 0.00
InMode (INMD) Israel $0.882B 8.89
Kestra Medical Technologies (KMTS) United States $0.854B 0.00
Curaleaf Holdings (CURLF) Canada $0.831B 0.00
Tilray Brands (TLRY) Canada $0.678B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.606B 0.00
Owens & Minor (OMI) United States $0.598B 4.96
Evolus (EOLS) United States $0.594B 0.00
CeriBell (CBLL) United States $0.550B 0.00
Valneva SE (VALN) France $0.540B 0.00
ZimVie (ZIMV) United States $0.522B 23.75
Surmodics (SRDX) United States $0.446B 0.00
SNDL (SNDL) Canada $0.415B 0.00
Sanuwave Health (SNWV) United States $0.328B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.315B 0.00
VAREX IMAGING (VREX) United States $0.305B 11.22
Cresco Labs (CRLBF) United States $0.302B 0.00
Capricor Therapeutics (CAPR) United States $0.286B 0.00
Aurora Cannabis (ACB) Canada $0.264B 78.33
Cerus (CERS) United States $0.264B 0.00
Quanterix (QTRX) United States $0.259B 0.00
Viemed Healthcare (VMD) United States $0.256B 21.57
OraSure Technologies (OSUR) United States $0.243B 0.00
Sanara MedTech (SMTI) United States $0.234B 0.00
Canopy Growth (CGC) Canada $0.230B 0.00
Brainsway (BWAY) Israel $0.228B 60.45
Biote (BTMD) United States $0.219B 6.17
Verano Holdings (VRNOF) United States $0.213B 0.00
Omeros (OMER) United States $0.213B 0.00
Organigram Global (OGI) Canada $0.196B 0.00
High Tide (HITI) Canada $0.194B 0.00
Utah Medical Products (UTMD) United States $0.180B 14.70
TriSalus Life Sciences (TLSI) United States $0.173B 0.00
Vireo Growth (VREOF) United States $0.151B 0.00
Exagen (XGN) United States $0.148B 0.00
FitLife Brands (FTLF) United States $0.122B 14.99
TerrAscend (TSNDF) Canada $0.121B 0.00
Jin Medical (ZJYL) China $0.101B 0.00
Fonar (FONR) United States $0.099B 12.82
MacroGenics (MGNX) United States $0.093B 0.00
Quipt Home Medical (QIPT) United States $0.088B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Veru (VERU) United States $0.085B 0.00
Jushi Holdings (JUSHF) United States $0.085B 0.00
Apyx Medical (APYX) United States $0.085B 0.00
Safety Shot (SHOT) United States $0.075B 0.00
InterCure (INCR) Israel $0.072B 0.00
Zynex (ZYXI) United States $0.071B 0.00
Cytosorbents (CTSO) United States $0.065B 0.00
Agape ATP (ATPC) $0.065B 0.00
ImmuCell (ICCC) United States $0.062B 0.00
United-Guardian (UG) United States $0.043B 14.87
Rockwell Medical (RMTI) United States $0.038B 0.00
Modular Medical (MODD) United States $0.038B 0.00
Nephros (NEPH) United States $0.038B 51.00
Allurion Technologies (ALUR) United States $0.024B 0.00
INLIF (INLF) $0.015B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Meihua Medical Technologies (MHUA) China $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
IM Cannabis (IMCC) Canada $0.012B 0.00
Senestech (SNES) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00